Erratum: Sustained translational repression by eIF2α -P mediates prion neurodegeneration (Nature (2012) 485 (507-511) DOI:10.1038/nature11058);Sustained translational repression by eIF2α-P mediates prion neurodegeneration

Nature

Volumn 485, Issue 7399, 2012, Pages 507-511

  Moreno, Julie A ^a   Radford, Helois ^a   Peretti, Diego ^a   Steinert, Joern R ^a   Verity, Nicholas ^a   Martin, Maria Guerra ^a   Halliday, Mark ^a   Morgan, Jason ^a   Dinsdale, David ^a   Ortori, Catherine A ^b   Barrett, David A ^c   Tsaytler, Pavel ^c   Bertolotti, Anne ^a   Willis, Anne E ^a   Bushell, Martin ^a   Mallucci, Giovanna R ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GADD34 PROTEIN; INITIATION FACTOR 2ALPHA; PRION PROTEIN; UNCLASSIFIED DRUG;

BIOACCUMULATION; DISEASE PREVALENCE; INFECTIVITY; INHIBITOR; NEUROLOGY; PHYSIOLOGICAL RESPONSE; PROTEIN; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CONTROLLED STUDY; DEGENERATIVE DISEASE; GENE REPRESSION; HIPPOCAMPUS; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN SYNTHESIS; RNA INTERFERENCE; RNA TRANSLATION; SIGNAL TRANSDUCTION; SYNAPSE; VIRUS REPLICATION;

EUKARYOTA; MUS;

EID: 84861450392     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature13569     Document Type: Erratum

References (34)

1. Hoozemans, J. J. et al. Activation of the unfolded protein response in Parkinson's disease. Biochem. Biophys. Res. Commun. 354, 707-711 (2007).
2. Hoozemans, J. J. et al. The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. Am. J. Pathol. 174, 1241-1251 (2009).
3. Hoozemans, J. J. et al. The unfolded protein response is activated in Alzheimer's disease. Acta Neuropathol. 110, 165-172 (2005).
4. Unterberger, U. et al. Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo. J. Neuropathol. Exp. Neurol. 65, 348-357 (2006).
5. Boyce, M. et al. A selective inhibitor of eIF2a dephosphorylation protects cells from ER stress. Science 307, 935-939 (2005).
6. Prusiner, S. B. Molecular biology of prion diseases. Science 252, 1515-1522 (1991).
7. Mallucci, G. et al. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302, 871-874 (2003).
8. Mallucci, G. R. et al. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 53, 325-335 (2007).
9. White, M. D. et al. Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc. Natl Acad. Sci. USA 105, 10238-10243 (2008).
10. Mallucci, G. R. et al. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J. 21, 202-210 (2002).
11. Kristiansen, M. et al. Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol. Cell 26, 175-188 (2007).
12. Ron, D. & Walter, P. Signal integration in the endoplasmic reticulum unfolded protein response. Nature Rev. Mol. Cell Biol. 8, 519-529 (2007).
13. Hetz, C., Russelakis-Carneiro, M., Maundrell, K., Castilla, J. & Soto, C. Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J. 22, 5435-5445 (2003).
14. Yoo, B. C. et al.Overexpressed protein disulfide isomerase in brains of patients with sporadic Creutzfeldt-Jakob disease. Neurosci. Lett. 334, 196-200 (2002).
15. Steele, A. D. et al. Diminishing apoptosis by deletion of Bax or overexpression of Bcl-2 does not protect against infectious prion toxicity in vivo. J. Neurosci. 27, 13022-13027 (2007).
16. Steele, A. D. et al. Prion pathogenesis is independent of caspase-12. Prion 1, 243-247 (2007).
17. Harding, H. P. et al. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell 6, 1099-1108 (2000)
18. Spriggs, K. A., Bushell, M. & Willis, A. E. Translational regulation of gene expression during conditions of cell stress. Mol. Cell 40, 228-237 (2010).
19. Bueler, H. et al. Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347 (1993).
20. Manson, J. C., Clarke, A. R., McBride, P. A., McConnell, I.& Hope, J. PrP gene dosage determines the timingbut not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 3, 331-340 (1994).
21. Sandberg, M. K., Al-Doujaily, H., Sharps, B., Clarke, A. R. & Collinge, J. Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 470, 540-542 (2011).
22. Tsaytler, P.,Harding, H. P., Ron, D.&Bertolotti, A. Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis. Science 332, 91-94 (2011).
23. Chafekar, S. M., Hoozemans, J. J., Zwart, R., Baas, F. & Scheper, W. Ab1-42 induces mild endoplasmic reticulum stress in an aggregation state-dependent manner. Antioxid. Redox Signal. 9, 2245-2254 (2007).
24. Wiseman, R. L. et al. Flavonol activation defines an unanticipated ligand-binding site in the kinase-RNase domain of IRE1. Mol. Cell 38, 291-304 (2010).
25. Sokka, A. L. et al. Endoplasmic reticulum stress inhibition protects against excitotoxic neuronal injury in the rat brain. J. Neurosci. 27, 901-908 (2007).
26. Saxena, S., Cabuy, E.&Caroni, P.Arole formotoneuron subtype-selectiveERstress in disease manifestations of FALS mice. Nature Neurosci. 12, 627-636 (2009).
27. Zhu, Y. et al. Eif-2a protects brainstem motoneurons in a murine model of sleep apnea. J. Neurosci. 28, 2168-2178 (2008).
28. Balch, W. E., Morimoto, R. I., Dillin, A.&Kelly, J. W. Adapting proteostasis for disease intervention. Science 319, 916-919 (2008).
29. White, M. D., Milne, R. V. & Nolan, M. F. A molecular toolbox for rapid generation of viral vectors to up-or down-regulate neuronal gene expression in vivo. Front. Mol. Neurosci. 4, 8 (2011).
30. Haustein, M. D. et al. Acute hyperbilirubinaemia induces presynaptic neurodegeneration at a central glutamatergic synapse. J. Physiol. (Lond.) 588, 4683-4693 (2011).
31. Steinert, J. R. et al. Nitric oxide is an activity-dependent regulator of target neuron intrinsic excitability. Neuron 71, 291-305 (2011).
32. Johannes, G. & Sarnow, P. Cap-independent polysomal association of natural mRNAs encoding c-myc, BiP, and eIF4G conferred by internal ribosome entry sites. RNA 4, 1500-1513 (1998).
33. Jiang, M., Deng, L. & Chen, G. High Ca21-phosphate transfection efficiency enables single neuron gene analysis. Gene Ther. 11, 1303-1311 (2004).
34. Cunningham, C. et al. Synaptic changes characterize early behavioural signs in the ME7 model ofmurine prion disease. Eur. J. Neurosci. 17, 2147-2155 (2003).